Bausch Health Companies Inc.

Bausch Health Companies Inc. develops, manufactures, and markets a portfolio of pharmaceutical, medical device, and over-the-counter health products. As a global pharmaceutical company, its core business of bringing new drugs and medical devices to market inherently requires animal testing to satisfy regulatory requirements for safety and efficacy. The company acknowledges this requirement in its Clinical Trials Policy, stating, "When animal testing is required... we are committed to utilizing the absolute minimum."

The company's product portfolio and pipeline are dependent on animal studies. For example, its prescription products like ARESTIN® for periodontal disease and Migranal nasal spray for migraines required animal data for FDA approval. Its subsidiary, Bausch + Lomb, also develops ophthalmic pharmaceuticals and devices that undergo animal testing. While the FDA and industry are exploring animal-free testing methods for some applications, such as certain monoclonal antibodies, regulatory approval for most new chemical entities and medical devices from Bausch Health continues to necessitate animal data. The company's business model is fundamentally tied to the animal testing required by global health authorities.